A generative AI prototype with Amazon Bedrock transforms life sciences and the genome analysis process
Favorite It takes biopharma companies over 10 years, at a cost of over $2 billion and with a failure rate of over 90%, to deliver a new drug to patients. The Market to Molecule (M2M) value stream process, which biopharma companies must apply to bring new drugs to patients, is
Read More
Shared by AWS Machine Learning May 29, 2025